Literature DB >> 23155233

Analysis of p53 and miRNA expression after irradiation of glioblastoma cell lines.

Akiko Sasaki1, Yuko Udaka, Yuko Tsunoda, Gou Yamamoto, Mayumi Tsuji, Hideto Oyamada, Katsuji Oguchi, Tohru Mizutani.   

Abstract

Glioblastoma is a malignant brain tumor that is difficult to completely cure by surgical treatment alone. However, resistance to anticancer drugs and radiation may be acquired during treatment. For instance, miRNAs involved in regulating the expression of genes inducing apoptosis and other specific genes have been proposed for use, in order to induce the apoptosis of radioresistant cancer cells. A172 glioblastoma cells, expressing wild-type p53 were irradiated to a total dose of up to 60 Gy allowing us to analyze the activities of apoptosis-related proteins. The miR-34a expression levels in cells after irradiation at 30 and 60 Gy were 0.17- and 18.7-times the BCL2 and caspase-9 expression levels, respectively. The high miR-34a expression level in the cells after irradiation at 60 Gy reduced the p53 expression level. This study suggests that apoptosis might be promoted by regulating the action of miRNAs, even in cells that have acquired radioresistance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23155233

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

Review 1.  Emergence of miR-34a in radiation therapy.

Authors:  Jerome Lacombe; Frederic Zenhausern
Journal:  Crit Rev Oncol Hematol       Date:  2016-12-01       Impact factor: 6.312

2.  A promising light for an impossible disease: miRNAs in malignant gliomas.

Authors:  Yin Yee Sharon Low; Wai Hoe Ng
Journal:  CNS Oncol       Date:  2013-03

Review 3.  Current progress for the use of miRNAs in glioblastoma treatment.

Authors:  Amanda Tivnan; Kerrie Leanne McDonald
Journal:  Mol Neurobiol       Date:  2013-04-28       Impact factor: 5.590

Review 4.  MicroRNAs involved in chemo- and radioresistance of high-grade gliomas.

Authors:  Andrej Besse; Jiri Sana; Pavel Fadrus; Ondrej Slaby
Journal:  Tumour Biol       Date:  2013-04-09

5.  MiR-34a regulates apoptosis in liver cells by targeting the KLF4 gene.

Authors:  Qiu Chen; Lei Li; Yu Tu; Lu Lin Zheng; Wei Liu; Xue Yong Zuo; Yong Ming He; Shu Yu Zhang; Wei Zhu; Jian Ping Cao; Feng Mei Cui; Jun Hou
Journal:  Cell Mol Biol Lett       Date:  2014-01-10       Impact factor: 5.787

6.  Plasma microRNA-720 may predict prognosis and diagnosis in glioma patients.

Authors:  Peng Chen; Guangying Zhang; Qin Zhou; Zhanzhan Li
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

Review 7.  MicroRNAs as prognostic markers and therapeutic targets in gliomas.

Authors:  Albert Sufianov; Sema Begliarzade; Tatiana Ilyasova; Yanchao Liang; Ozal Beylerli
Journal:  Noncoding RNA Res       Date:  2022-07-06

8.  Enhancing the Effects of Low Dose Doxorubicin Treatment by the Radiation in T47D and SKBR3 Breast Cancer Cells.

Authors:  Fahimeh Aghaee; Jalil Pirayesh Islamian; Behzad Baradaran; Asghar Mesbahi; Mohammad Mohammadzadeh; Mohammad Asghari Jafarabadi
Journal:  J Breast Cancer       Date:  2013-06-28       Impact factor: 3.588

9.  Visualizing molecular profiles of glioblastoma with GBM-BioDP.

Authors:  Orieta Celiku; Seth Johnson; Shuping Zhao; Kevin Camphausen; Uma Shankavaram
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

10.  Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome.

Authors:  Yao Zhang; Ye Hu; Jing-Yuan Fang; Jie Xu
Journal:  Oncotarget       Date:  2016-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.